Syngene International schedules analyst meetings on June 10-11

2 min read     Updated on 06 Jun 2026, 10:20 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Syngene International Limited has scheduled group meetings with 15 analysts and institutional investors on June 10 and 11, 2026, in Bengaluru. The company stated that no unpublished price sensitive information will be shared during these sessions, which are conducted pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

powered bylight_fuzz_icon
42208935

*this image is generated using AI for illustrative purposes only.

Syngene International Limited has scheduled a series of meetings with analysts and institutional investors on June 10 and June 11, 2026, in Bengaluru. The company confirmed that no unpublished price sensitive information (UPSI) will be disclosed during these sessions. The meetings are being held pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The schedule includes group meetings with 15 distinct entities, ranging from domestic mutual funds to international investment advisors. The sessions are divided into two time slots across the two days. On June 10, 2026, meetings are set for 3:00 PM IST, while the June 11, 2026, sessions are scheduled for 11:00 AM IST.

Meeting Schedule

Sl. No. Date Name of the Analyst/Investor Type of meeting Timing (IST) Venue
1. June 10, 2026 Amansa Inv Advisors Pvt Ltd In Person 3:00 PM Bengaluru
2. June 10, 2026 Creaegis Advisors LLP In Person 3:00 PM Bengaluru
3. June 10, 2026 ICICI Prudential Life Insurance Co Ltd In Person 3:00 PM Bengaluru
4. June 10, 2026 NV Capital Services In Person 3:00 PM Bengaluru
5. June 10, 2026 Susquehanna International Group In Person 3:00 PM Bengaluru
6. June 10, 2026 Tree Line Advisors (Singapore) Pte Ltd In Person 3:00 PM Bengaluru
7. June 10, 2026 UG Inv Advisers Ltd – Taipei In Person 3:00 PM Bengaluru
8. June 10, 2026 Invesco In Person 3:00 PM Bengaluru
9. June 10, 2026 Goldman Sachs In Person 3:00 PM Bengaluru
10. June 11, 2026 Julius Baer In Person 11:00 AM Bengaluru
11. June 11, 2026 Lion Global, Singapore In Person 11:00 AM Bengaluru
12. June 11, 2026 Ninety One, London In Person 11:00 AM Bengaluru
13. June 11, 2026 Quantum Mutual Fund In Person 11:00 AM Bengaluru
14. June 11, 2026 Tata AIA General Insurance In Person 11:00 AM Bengaluru
15. June 11, 2026 Macquarie India In Person 11:00 AM Bengaluru

The intimation was signed by Chethan Yogesh, Company Secretary & Compliance Officer, on June 05, 2026. The information is also available on the company's official website.

Historical Stock Returns for Syngene International

1 Day5 Days1 Month6 Months1 Year5 Years
-1.16%-0.83%-3.01%-29.72%-32.32%-25.09%

What strategic priorities or growth themes is Syngene likely to emphasize during these non-deal roadshows?

How might the engagement with international investors like Ninety One and Julius Baer influence Syngene's global investor base?

Could these meetings signal an upcoming shift in Syngene's capital allocation strategy or M&A outlook?

like17
dislike

Syngene Seeks Nod for Kiran Mazumdar-Shaw as Executive Chairperson

1 min read     Updated on 22 May 2026, 09:19 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Syngene International Limited has initiated a postal ballot process to secure shareholder approval for appointing Ms. Kiran Mazumdar-Shaw as Executive Chairperson, effective April 1, 2026. The role change designates her as a Key Managerial Personnel with a proposed remuneration of ₹4.00 Crores per annum. The company has set the remote e-voting period from May 21, 2026, to June 19, 2026, with results expected by June 23, 2026.

powered bylight_fuzz_icon
40848163

*this image is generated using AI for illustrative purposes only.

Syngene International Limited has announced a postal ballot to seek shareholder approval for the appointment of Ms. Kiran Mazumdar-Shaw as Executive Chairperson. The resolution proposes changing her role from Non-Executive Chairperson to Executive Chairperson, classified as a Key Managerial Personnel, effective April 1, 2026. The proposal also includes the approval of managerial remuneration up to ₹4 crore per annum.

Remuneration Details

The Board of Directors has recommended a monthly salary of ₹33.33 Lakhs, amounting to ₹4.00 Crores annually. This figure includes contributions to the Provident Fund and Gratuity Fund. The total aggregate salary is capped at ₹4.00 Crores per annum, excluding reimbursements for reasonable travelling, entertainment, and other out-of-pocket expenses incurred in the performance of her duties. The tenure for this appointment is proposed for a period of five years.

E-Voting Schedule

The company has engaged KFin Technologies Limited to facilitate remote e-voting. Shareholders whose names appear in the Register of Members or List of Beneficial Owners as of the cut-off date are eligible to participate. The key dates for the voting process are outlined below:

Description Date and Time
Cut-off date for eligibility Friday, May 15, 2026
Commencement of remote e-voting Thursday, May 21, 2026 (9:00 AM IST)
Conclusion of remote e-voting Friday, June 19, 2026 (5:00 PM IST)
Date of declaration of results On or before Tuesday, June 23, 2026

Postal Ballot Notice

The postal ballot notice was dispatched electronically on Wednesday, May 20, 2026. The resolution requires a special majority for approval. If passed, the resolution will be deemed to have been passed on the last date of the remote e-voting period, Friday, June 19, 2026. The results will be communicated to the stock exchanges and displayed on the company's website.

Ms. Kiran Mazumdar-Shaw is currently the Non-Executive Chairperson and Promoter of Syngene International . The Board recommends the resolution, stating that the change in role is in the best interests of the Company and its stakeholders, leveraging her extensive experience and leadership.

Historical Stock Returns for Syngene International

1 Day5 Days1 Month6 Months1 Year5 Years
-1.16%-0.83%-3.01%-29.72%-32.32%-25.09%

How might Kiran Mazumdar-Shaw's transition to Executive Chairperson affect Syngene's strategic direction and its competitive positioning in the contract research and manufacturing services sector?

What operational or governance changes could shareholders expect at Syngene following the shift from a non-executive to an executive leadership structure?

Could this leadership transition signal potential mergers, acquisitions, or major partnerships that Syngene may be pursuing in the near term?

like17
dislike

More News on Syngene International

1 Year Returns:-32.32%